ReP USP - Resultado da busca

Parte de monografia/livro
Immune reconstitution in rheumatic disease patients after autologous hematopoietic stem cell transplantation (2024)
Gonçalves, Maynara Santana; Farias, Kelen Cristina Ribeiro Malmegrim de ; Farge, Dominique; Oliveira, Maria Carolina
Source: Handbook of Clinical Neurology: Hematopoietic Stem Cell Transplantation for Neurologic Diseases. Unidades: FCFRP, FMRP
Subjects: TRANSPLANTES, CÉLULAS-TRONCO, QUIMIOTERAPIA, DOENÇAS AUTOIMUNES, DOENÇAS REUMÁTICAS, IMUNOLOGIA, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Maynara Santana et al. Immune reconstitution in rheumatic disease patients after autologous hematopoietic stem cell transplantation. Handbook of Clinical Neurology: Hematopoietic Stem Cell Transplantation for Neurologic Diseases. Tradução . Amsterdam: Elsevier, 2024. v. 202 (325 p.). . Disponível em: https://doi.org/10.1016/B978-0-323-90242-7.00015-8. Acesso em: 05 maio 2026.
APA
Gonçalves, M. S., Farias, K. C. R. M. de, Farge, D., & Oliveira, M. C. (2024). Immune reconstitution in rheumatic disease patients after autologous hematopoietic stem cell transplantation. In Handbook of Clinical Neurology: Hematopoietic Stem Cell Transplantation for Neurologic Diseases (Vol. 202 (325 p.). Amsterdam: Elsevier. doi:10.1016/B978-0-323-90242-7.00015-8
NLM
Gonçalves MS, Farias KCRM de, Farge D, Oliveira MC. Immune reconstitution in rheumatic disease patients after autologous hematopoietic stem cell transplantation [Internet]. In: Handbook of Clinical Neurology: Hematopoietic Stem Cell Transplantation for Neurologic Diseases. Amsterdam: Elsevier; 2024. [citado 2026 maio 05 ] Available from: https://doi.org/10.1016/B978-0-323-90242-7.00015-8
Vancouver
Gonçalves MS, Farias KCRM de, Farge D, Oliveira MC. Immune reconstitution in rheumatic disease patients after autologous hematopoietic stem cell transplantation [Internet]. In: Handbook of Clinical Neurology: Hematopoietic Stem Cell Transplantation for Neurologic Diseases. Amsterdam: Elsevier; 2024. [citado 2026 maio 05 ] Available from: https://doi.org/10.1016/B978-0-323-90242-7.00015-8
Artigo de periodico-carta/editorial
Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism. [Carta]: 2022 updated systematic review and meta-analysis of randomized controlled trials (2022)
Frere, Corinne; Farge, Dominique; Schrag, Deborah; Prata, Pedro Henrique de Lima ; Connors, Jean M.
Source: Journal of Hematology & Oncology. Unidade: FMRP
Subjects: ANTICOAGULANTES, TROMBOEMBOLISMO, NEOPLASIAS, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRERE, Corinne et al. Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism. [Carta]: 2022 updated systematic review and meta-analysis of randomized controlled trials. Journal of Hematology & Oncology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13045-022-01289-1. Acesso em: 05 maio 2026. , 2022
APA
Frere, C., Farge, D., Schrag, D., Prata, P. H. de L., & Connors, J. M. (2022). Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism. [Carta]: 2022 updated systematic review and meta-analysis of randomized controlled trials. Journal of Hematology & Oncology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1186/s13045-022-01289-1
NLM
Frere C, Farge D, Schrag D, Prata PH de L, Connors JM. Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism. [Carta]: 2022 updated systematic review and meta-analysis of randomized controlled trials [Internet]. Journal of Hematology & Oncology. 2022 ; 15( 1):[citado 2026 maio 05 ] Available from: https://doi.org/10.1186/s13045-022-01289-1
Vancouver
Frere C, Farge D, Schrag D, Prata PH de L, Connors JM. Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism. [Carta]: 2022 updated systematic review and meta-analysis of randomized controlled trials [Internet]. Journal of Hematology & Oncology. 2022 ; 15( 1):[citado 2026 maio 05 ] Available from: https://doi.org/10.1186/s13045-022-01289-1
Artigo de periodico
A review of latest clinical practice guidelines for the management of cancer-associated thrombosis (2022)
Frere, Corinne; Wahl, Clementine; Rueda-Camino, Jose A.; Crichi, Benjamin; Prata, Pedro Henrique de Lima ; Marjanovic, Zora; Farge, Dominique
Source: Best Practice & Research: Clinical Haematology. Unidade: FMRP
Subjects: TROMBOSE, NEOPLASIAS, PRÁTICA CLÍNICA, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRERE, Corinne et al. A review of latest clinical practice guidelines for the management of cancer-associated thrombosis. Best Practice & Research: Clinical Haematology, v. 35, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.beha.2022.101348. Acesso em: 05 maio 2026.
APA
Frere, C., Wahl, C., Rueda-Camino, J. A., Crichi, B., Prata, P. H. de L., Marjanovic, Z., & Farge, D. (2022). A review of latest clinical practice guidelines for the management of cancer-associated thrombosis. Best Practice & Research: Clinical Haematology, 35, 1-20. doi:10.1016/j.beha.2022.101348
NLM
Frere C, Wahl C, Rueda-Camino JA, Crichi B, Prata PH de L, Marjanovic Z, Farge D. A review of latest clinical practice guidelines for the management of cancer-associated thrombosis [Internet]. Best Practice & Research: Clinical Haematology. 2022 ; 35 1-20.[citado 2026 maio 05 ] Available from: https://doi.org/10.1016/j.beha.2022.101348
Vancouver
Frere C, Wahl C, Rueda-Camino JA, Crichi B, Prata PH de L, Marjanovic Z, Farge D. A review of latest clinical practice guidelines for the management of cancer-associated thrombosis [Internet]. Best Practice & Research: Clinical Haematology. 2022 ; 35 1-20.[citado 2026 maio 05 ] Available from: https://doi.org/10.1016/j.beha.2022.101348
Artigo de periodico
New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis (2021)
Burt, Richard K.; Muraro, Paolo A.; Farge, Dominique; Oliveira, Maria Carolina; Snowden, John A.; Saccardi, Riccardo; Han, Xiaoqiang; Quigley, Kathleen; Bueno, Valquiria; Frasca, Daniela; Fedorenko, Denis; Burman, Joachim
Source: Bone Marrow Transplantation. Unidade: FMRP
Subjects: DOENÇAS AUTOIMUNES, DOENÇA ENXERTO-HOSPEDEIRO, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, ESCLEROSE MÚLTIPLA, TRANSPLANTE AUTÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURT, Richard K. et al. New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplantation, v. 56, n. 7, p. 1509-1517, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41409-021-01277-y. Acesso em: 05 maio 2026.
APA
Burt, R. K., Muraro, P. A., Farge, D., Oliveira, M. C., Snowden, J. A., Saccardi, R., et al. (2021). New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplantation, 56( 7), 1509-1517. doi:10.1038/s41409-021-01277-y
NLM
Burt RK, Muraro PA, Farge D, Oliveira MC, Snowden JA, Saccardi R, Han X, Quigley K, Bueno V, Frasca D, Fedorenko D, Burman J. New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis [Internet]. Bone Marrow Transplantation. 2021 ; 56( 7): 1509-1517.[citado 2026 maio 05 ] Available from: https://doi.org/10.1038/s41409-021-01277-y
Vancouver
Burt RK, Muraro PA, Farge D, Oliveira MC, Snowden JA, Saccardi R, Han X, Quigley K, Bueno V, Frasca D, Fedorenko D, Burman J. New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis [Internet]. Bone Marrow Transplantation. 2021 ; 56( 7): 1509-1517.[citado 2026 maio 05 ] Available from: https://doi.org/10.1038/s41409-021-01277-y
Artigo de periodico
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party (2021)
Henes, Joerg; Oliveira, Maria Carolina; Labopin, Myriam; Badoglio, Manuela; Scherer, Hans Ulrich; Del Papa, Nicoletta; Daikeler, Thomas; Schmalzing, Marc; Schroers, Roland; Martin, Thierry; Pugnet, Gregory; Simões, Belinda Pinto; Michonneau, David; Marijt, Erik W. A.; Lioure, Bruno; Bay, Jacques Olivier; Snowden, John A.; Rovira, Montserrat; Huynh, Anne; Onida, Francesco; Kanz, Lothar; Marjanovic, Zora; Farge, Dominique
Source: Haematologica: the hematology journal. Unidade: FMRP
Subjects: ENVELHECIMENTO, DOENÇAS AUTOIMUNES, MEDULA ÓSSEA, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, ESTUDOS PROSPECTIVOS, TRANSPLANTE AUTÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HENES, Joerg et al. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party. Haematologica: the hematology journal, v. 106, n. 2, p. 375-383, 2021Tradução . . Disponível em: https://doi.org/10.3324/haematol.2019.230128. Acesso em: 05 maio 2026.
APA
Henes, J., Oliveira, M. C., Labopin, M., Badoglio, M., Scherer, H. U., Del Papa, N., et al. (2021). Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party. Haematologica: the hematology journal, 106( 2), 375-383. doi:10.3324/haematol.2019.230128
NLM
Henes J, Oliveira MC, Labopin M, Badoglio M, Scherer HU, Del Papa N, Daikeler T, Schmalzing M, Schroers R, Martin T, Pugnet G, Simões BP, Michonneau D, Marijt EWA, Lioure B, Bay JO, Snowden JA, Rovira M, Huynh A, Onida F, Kanz L, Marjanovic Z, Farge D. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party [Internet]. Haematologica: the hematology journal. 2021 ; 106( 2): 375-383.[citado 2026 maio 05 ] Available from: https://doi.org/10.3324/haematol.2019.230128
Vancouver
Henes J, Oliveira MC, Labopin M, Badoglio M, Scherer HU, Del Papa N, Daikeler T, Schmalzing M, Schroers R, Martin T, Pugnet G, Simões BP, Michonneau D, Marijt EWA, Lioure B, Bay JO, Snowden JA, Rovira M, Huynh A, Onida F, Kanz L, Marjanovic Z, Farge D. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party [Internet]. Haematologica: the hematology journal. 2021 ; 106( 2): 375-383.[citado 2026 maio 05 ] Available from: https://doi.org/10.3324/haematol.2019.230128
Parte de monografia/livro
Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? (2020)
Farias, Kelen Cristina Ribeiro Malmegrim de ; Toubert, Antoine; Farge, Dominique; Rodrigues, Maria Carolina de Oliveira
Source: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Unidades: FCFRP, FMRP
Subjects: TRANSPLANTES, CÉLULAS-TRONCO, DOENÇAS AUTOIMUNES, EDITORIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIAS, Kelen Cristina Ribeiro Malmegrim de et al. Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 05 maio 2026.
APA
Farias, K. C. R. M. de, Toubert, A., Farge, D., & Rodrigues, M. C. de O. (2020). Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9
NLM
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2026 maio 05 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Vancouver
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2026 maio 05 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Artigo de periodico-carta/editorial
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? (2020)
Farias, Kelen Cristina Ribeiro Malmegrim de ; Toubert, Antoine; Farge, Dominique; Rodrigues, Maria Carolina de Oliveira
Source: Frontiers in Immunology. Unidades: FCFRP, FMRP
Subjects: TRANSPLANTES, CÉLULAS-TRONCO, DOENÇAS AUTOIMUNES, EDITORIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIAS, Kelen Cristina Ribeiro Malmegrim de et al. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand?. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fimmu.2019.03044. Acesso em: 05 maio 2026. , 2020
APA
Farias, K. C. R. M. de, Toubert, A., Farge, D., & Rodrigues, M. C. de O. (2020). Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.3389/fimmu.2019.03044
NLM
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? [Internet]. Frontiers in Immunology. 2020 ; 10[citado 2026 maio 05 ] Available from: https://doi.org/10.3389/fimmu.2019.03044
Vancouver
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? [Internet]. Frontiers in Immunology. 2020 ; 10[citado 2026 maio 05 ] Available from: https://doi.org/10.3389/fimmu.2019.03044
Artigo de periodico
Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis (2018)
Arruda, Lucas C. M. ; Lima-Júnior, João R.; Clave, Emmanuel; Moraes, Daniela A.; Douay, Corinne; Fournier, Isabelle; Moins-Teisserenc, Hélène; Covas, Dimas Tadeu ; Simões, Belinda Pinto ; Farge, Dominique; Toubert, Antoine; Farias, Kelen Cristina Ribeiro Malmegrim de ; Oliveira, Maria Carolina
Source: Bone Marrow Transplantation. Unidades: FMRP, FCFRP
Subjects: TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Lucas C. M. et al. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis. Bone Marrow Transplantation, v. 53, n. 10, p. 1319-1327, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41409-018-0162-0. Acesso em: 05 maio 2026.
APA
Arruda, L. C. M., Lima-Júnior, J. R., Clave, E., Moraes, D. A., Douay, C., Fournier, I., et al. (2018). Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis. Bone Marrow Transplantation, 53( 10), 1319-1327. doi:10.1038/s41409-018-0162-0
NLM
Arruda LCM, Lima-Júnior JR, Clave E, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Covas DT, Simões BP, Farge D, Toubert A, Farias KCRM de, Oliveira MC. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis [Internet]. Bone Marrow Transplantation. 2018 ; 53( 10): 1319-1327.[citado 2026 maio 05 ] Available from: https://doi.org/10.1038/s41409-018-0162-0
Vancouver
Arruda LCM, Lima-Júnior JR, Clave E, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Covas DT, Simões BP, Farge D, Toubert A, Farias KCRM de, Oliveira MC. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis [Internet]. Bone Marrow Transplantation. 2018 ; 53( 10): 1319-1327.[citado 2026 maio 05 ] Available from: https://doi.org/10.1038/s41409-018-0162-0
Artigo de periodico
Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis (2017)
Muraro, Paolo A.; Pasquini, Marcelo; Atkins, Harold L.; Bowen, James D.; Farge, Dominique; Fassas, Athanasios; Freedman, Mark S.; Georges, George E.; Gualandi, Francesca; Simões, Belinda Pinto
Source: JAMA Neurology. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, ESCLEROSE MÚLTIPLA, TRANSPLANTE AUTÓLOGO, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MURARO, Paolo A. et al. Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis. JAMA Neurology, v. 74, n. 4, p. 459-469, 2017Tradução . . Disponível em: https://doi.org/10.1001/jamaneurol.2016.5867. Acesso em: 05 maio 2026.
APA
Muraro, P. A., Pasquini, M., Atkins, H. L., Bowen, J. D., Farge, D., Fassas, A., et al. (2017). Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis. JAMA Neurology, 74( 4), 459-469. doi:10.1001/jamaneurol.2016.5867
NLM
Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Simões BP. Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis [Internet]. JAMA Neurology. 2017 ; 74( 4): 459-469.[citado 2026 maio 05 ] Available from: https://doi.org/10.1001/jamaneurol.2016.5867
Vancouver
Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Simões BP. Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis [Internet]. JAMA Neurology. 2017 ; 74( 4): 459-469.[citado 2026 maio 05 ] Available from: https://doi.org/10.1001/jamaneurol.2016.5867
Artigo de periodico
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT autoimmune diseases working party (2015)
Greco, Raffaella; Bondanza, Attilio; Oliveira, Maria Carolina; Badoglio, Manuela; Burman, Joachim; Piehl, Fredrik; Hagglund, Hans; Krasulova, Eva; Simões, Belinda Pinto; Carlson, Kristina; Pohlreich, David; Labopin, Myriam; Saccardi, Riccardo; Comi, Giancarlo; Mancardi, Gian Luigi; Bacigalupo, Andrea; Ciceri, Fabio; Farge, Dominique
Source: Multiple Sclerosis Journal. Unidade: FMRP
Subjects: NEUROMIELITE ÓPTICA, TRANSPLANTE DE MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRECO, Raffaella et al. Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT autoimmune diseases working party. Multiple Sclerosis Journal, v. 21, n. 2, p. 189-197, 2015Tradução . . Disponível em: https://doi.org/10.1177/1352458514541978. Acesso em: 05 maio 2026.
APA
Greco, R., Bondanza, A., Oliveira, M. C., Badoglio, M., Burman, J., Piehl, F., et al. (2015). Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT autoimmune diseases working party. Multiple Sclerosis Journal, 21( 2), 189-197. doi:10.1177/1352458514541978
NLM
Greco R, Bondanza A, Oliveira MC, Badoglio M, Burman J, Piehl F, Hagglund H, Krasulova E, Simões BP, Carlson K, Pohlreich D, Labopin M, Saccardi R, Comi G, Mancardi GL, Bacigalupo A, Ciceri F, Farge D. Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT autoimmune diseases working party [Internet]. Multiple Sclerosis Journal. 2015 ; 21( 2): 189-197.[citado 2026 maio 05 ] Available from: https://doi.org/10.1177/1352458514541978
Vancouver
Greco R, Bondanza A, Oliveira MC, Badoglio M, Burman J, Piehl F, Hagglund H, Krasulova E, Simões BP, Carlson K, Pohlreich D, Labopin M, Saccardi R, Comi G, Mancardi GL, Bacigalupo A, Ciceri F, Farge D. Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT autoimmune diseases working party [Internet]. Multiple Sclerosis Journal. 2015 ; 21( 2): 189-197.[citado 2026 maio 05 ] Available from: https://doi.org/10.1177/1352458514541978
Artigo de periodico
Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysi (2013)
Burt, Richard K; Oliveira, Maria Carolina; Shah, Sanjiv J; Moraes, Daniela A; Simoes, Belinda Pinto; Gheorghiade, Mihai; Schroeder, James; Ruderman, Eric; Farge, Dominique; Chai, Z. Jessie; Marjanovic, Zora; Jain, Sandeep; Morgan, Amy; Milanetti, Francesca; Han, Xiaoqiang; Jovanovic, Borko; Helenowski, Irene B.; Voltarelli, Julio Cesar
Source: The Lancet. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, TRANSPLANTES, SEPSE, PERICARDITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURT, Richard K et al. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysi. The Lancet, v. 381, n. 9872, p. 1116-1124, 2013Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(12)62114-X. Acesso em: 05 maio 2026.
APA
Burt, R. K., Oliveira, M. C., Shah, S. J., Moraes, D. A., Simoes, B. P., Gheorghiade, M., et al. (2013). Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysi. The Lancet, 381( 9872), 1116-1124. doi:10.1016/S0140-6736(12)62114-X
NLM
Burt RK, Oliveira MC, Shah SJ, Moraes DA, Simoes BP, Gheorghiade M, Schroeder J, Ruderman E, Farge D, Chai ZJ, Marjanovic Z, Jain S, Morgan A, Milanetti F, Han X, Jovanovic B, Helenowski IB, Voltarelli JC. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysi [Internet]. The Lancet. 2013 ; 381( 9872): 1116-1124.[citado 2026 maio 05 ] Available from: https://doi.org/10.1016/S0140-6736(12)62114-X
Vancouver
Burt RK, Oliveira MC, Shah SJ, Moraes DA, Simoes BP, Gheorghiade M, Schroeder J, Ruderman E, Farge D, Chai ZJ, Marjanovic Z, Jain S, Morgan A, Milanetti F, Han X, Jovanovic B, Helenowski IB, Voltarelli JC. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysi [Internet]. The Lancet. 2013 ; 381( 9872): 1116-1124.[citado 2026 maio 05 ] Available from: https://doi.org/10.1016/S0140-6736(12)62114-X

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Indexado em

Non normalized affiliation

Countries of institutions of collaboration